Search Results:
CLINICAL TRIAL 17431
A Randomized Phase 3 Study of the Efficacy and Safety of Glufosfamide Compared with Fluorouracil (5-FU) in Patients with Metastatic Pancreatic Adenocarcinoma Previously Treated with Gemcitabine
Disease Site: Colon, Liver, Lung, Other Endocrine System, Pancreas, Small Intestine, Stomach
View Trial DetailsCLINICAL TRIAL 20345
Phase I/II Trial of Pre-Operative Image Guided Intensity Modulated Proton Radiation Therapy (IMPT) or Photon (IMRT) with Simultaneously Integrated Boost to the High Margin for Retroperitoneal Sarcomas
Disease Site: Anal, Colon, Kidney, Other genitourinary, Pancreas, Rectum, Sarcoma
View Trial DetailsCLINICAL TRIAL 21180
A First-in-Human, Two-Part, Open-Label, Clinical Study to Assess the Safety, Tolerability and Activity of Intravenous Doses of ICT01 as Monotherapy and in Combination with an Immune Checkpoint Inhibitor, in Patients with Advanced-Stage, Relapsed/Refractory Cancer (EVICTION Study)
Disease Site: Any Site, Breast, Colon, Larynx, Leukemia, other, Lip, Oral Cavity and Pharynx, Lung, Melanoma, skin, Ovary, Prostate, Stomach, Urinary Bladder
View Trial DetailsCLINICAL TRIAL 21336
A Phase I/Ib Global, Multicenter, Open-Label Umbrella Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients with Metastatic Colorectal Cancer (Intrinsic)
Disease Site: Colon
View Trial DetailsCLINICAL TRIAL 21459
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease (CIRCULATE-US)
Disease Site: Colon
View Trial DetailsCLINICAL TRIAL 21565
An Open-Label, Multi-center, Phase II Platform Study Evaluating the Efficacy and Safety of NIS793 and Other New Investigational Drug Combinations with Standard of Care (SOC) Anti-Cancer Therapy for the Second Line Treatment of Metastatic Colorectal Cancer (mCRC)
Disease Site: Colon, Rectum
View Trial DetailsCLINICAL TRIAL 21636
A Dose-Escalation and Expansion Study of the Safety and Efficacy of XL092 in Combination with Immuno-Oncology Agents in Subjects with Unresectable Advanced or Metastatic Solid Tumors
Disease Site: Breast, Colon, Prostate, Urinary Bladder
View Trial DetailsCLINICAL TRIAL 21881
A Phase 1b/2, Open-Label Study of Amivantamab Monotherapy and in Combination with Chemotherapy in Patients with Advanced or Metastatic Colorectal Cancer
Disease Site: Colon
View Trial DetailsCLINICAL TRIAL 21945
Phase 2, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Topically Administered LUT014 in Metastatic Colorectal Cancer Patients with EGFR Inhibitor Induced Acneiform Lesions Protocol
Disease Site: Colon
View Trial DetailsCLINICAL TRIAL 22284
A Phase lb Study of TBio-4101 (Autologous Selected and Expanded Tumor-Infiltrating Lymphocytes [TIL]) and Pembrolizumab in Patients with Advanced Solid Tumor Malignancies (STARLING)
Disease Site: Breast, Colon, Melanoma, skin, Rectum
View Trial DetailsCLINICAL TRIAL 22117
STRONG-PD: Support Through Remote Observation And Nutrition Guidance (STRONG) Program For Cancer Patients With Peritoneal Disease
Disease Site: Colon, Other Digestive Organ
View Trial DetailsCLINICAL TRIAL 16028
Transdisciplinary Research in Colorectal Cancer: The ColoCare Study
Disease Site: Colorectal, Colon, Rectum
View Trial DetailsCLINICAL TRIAL 21589
BASECAMP-1: An Observational Study Obtaining Solid Tumor Tissue from Subjects with Primary Surgical Resection and Leukapheresis for CAR T-Cell Therapy Manufacturing
Disease Site: Breast, Colon, Esophagus, Lip, Oral Cavity and Pharynx, Lung, Ovary, Pancreas, Rectum, Stomach
View Trial DetailsCLINICAL TRIAL 22176
Pilot to Create and Refine eHealth Genetic Education for Early-Onset Colorectal Cancer Patients (Nest-CRC Pilot)
Disease Site: Colon, Rectum
View Trial Details
